通过突变RAS进行GTP水解的药理恢复
Antonio Cuevas-Navarro1, Yasin Pourfarjam1, Feng Hu1
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature
|October 30, 2024
概括
新的三复合抑制剂通过恢复GTPase活性为RAS突变癌症提供了一种新的治疗策略. 这些分子粘合剂使用环素A (CYPA) 刺激GTP水解,抑制癌细胞的增殖.
科学领域:
- 癌症学
- 分子生物学
- 药物发现
背景情况:
- 每年约有340万癌症患者经常发生RAS原基因 (KRAS,NRAS,HRAS) 突变.
- 在RAS突变损害GTPase活动,导致不受控制的细胞信号和增殖.
- 以往针对RAS突变的治疗策略没有成功.
研究的目的:
- 研究三复合抑制剂作为RAS突变癌症的新疗法.
- 阐明这些抑制剂的双重作用机制.
主要方法:
- 使用旨在将环素A (CYPA) 引入RAS活性状态的三复合抑制剂.
- 研究了这些抑制剂对RAS效应体结合和GTP水解的影响.
- 通过药物结合的CYPA复合体对RAS残留的突变特异调节进行了分析.
主要成果:
- 三复合抑制剂表现出一种双重机制:抑制RAS效应因子结合和刺激GTP水解.
- 药物结合的 CYPA 复合物调节了 RAS 开关 II 基因残留物,以突变特异的方式促进了 GTP 水解.
- 对GTPase活性刺激敏感的RAS突变体对治疗的敏感性更大.
结论:
- 对于特定的RAS突变物,GTP水解的药理刺激增强了三复合抑制剂的治疗效果.
- 这项研究为开发通过增强突变RAS GTPase活性来抑制癌症生长的治疗方法奠定了基础.
相关概念视频
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
GTPases and their Regulation
8.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.3K
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K


